Inovio Pharmaceuticals
INO
#8897
Rank
NZ$0.24 B
Marketcap
NZ$3.58
Share price
2.48%
Change (1 day)
-49.46%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.13 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$79.24 M-6.5%
2023-12-31NZ$84.76 M-57.35%
2022-12-31NZ$0.19 B40.99%
2021-12-31NZ$0.14 B29.33%
2020-12-31NZ$0.10 B-47.03%
2019-12-31NZ$0.20 B213.04%
2018-12-31NZ$65.71 M4.29%
2017-12-31NZ$63.01 M-13.28%
2016-12-31NZ$72.65 M31.18%
2015-12-31NZ$55.38 M114.33%
2014-12-31NZ$25.84 M-39.99%
2013-12-31NZ$43.05 M244.53%
2012-12-31NZ$12.49 M-26.36%
2011-12-31NZ$16.97 M46.02%
2010-12-31NZ$11.62 M-56.59%
2009-12-31NZ$26.77 M-21.86%
2008-12-31NZ$34.25 M200.24%
2007-12-31NZ$11.41 M-35.42%
2006-12-31NZ$17.66 M119.25%
2005-12-31NZ$8.05 M6.45%
2004-12-31NZ$7.57 M316.58%
2003-12-31NZ$1.81 M-43.85%
2002-12-31NZ$3.23 M-19.55%
2001-12-31NZ$4.02 M
2001-03-31NZ$4.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$200.16 B 149,869.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.53 B 147,151.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$1.49 B 1,016.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.25 B 81,005.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$134.39 B 100,591.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$106.08 B 79,381.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$64.18 B 47,986.00%๐Ÿ‡บ๐Ÿ‡ธ USA